Jeremy P. Harris
Biography
Jeremy P. Harris, M.D., M.Phil., is an Associate Professor and Vice Chair of Clinical Operations in the Department of Radiation Oncology at the University of California, Irvine, where he also serves as Director of Thoracic Radiation Oncology at the Chao Family Comprehensive Cancer Center. Dr. Harris received his Doctor of Medicine degree from Stanford University, where he completed his residency training in radiation oncology, and holds a Master of Philosophy in Chemistry from the University of Cambridge, where he studied as a Churchill Scholar. His clinical and research focus centers on thoracic malignancies and sarcomas, with particular emphasis on combining radiation therapy with novel treatment modalities and addressing health disparities in cancer care.
Dr. Harris has secured multiple research grants as principal investigator, including an NCI Early Career Cancer Clinical Investigator Award and funding for clinical trials investigating combinations of immunotherapy with stereotactic ablative radiotherapy for sarcoma patients and novel applications of pulsed electric field ablation with radiation for lung tumors. He serves as principal investigator for a multi-institutional NCI-funded Phase III randomized trial testing ultra-hypofractionated radiation versus standard fractionation for high-risk soft tissue sarcoma. His research portfolio also includes studies examining financial toxicity in cancer patients and cost-effectiveness analyses of cancer screening programs.
Dr. Harris maintains active roles in national cooperative groups, serving on the SWOG Radiation Oncology Committee, Sarcoma Working Group, and Early Therapeutics and Rare Cancers Committee, as well as the NRG Developmental Therapeutics RT Committee. He serves as Associate Section Editor for Thoracic Cancers at the International Journal of Radiation Oncology, Biology, Physics. Dr. Harris has authored over 60 peer-reviewed publications and has contributed book chapters on radiation therapy for thoracic cancers and stereotactic body radiation therapy.
Return to topEducation
- B.S. in Chemical and Biomolecular Engineering, Johns Hopkins University, 2008
- M.Phil. in Chemistry, University of Cambridge, 2009
- M.D., Stanford University, 2014
Distinctions
- Churchill Scholar, The Winston Churchill Foundation, 2009
- Honorary Cambridge Overseas Trust Scholar, University of Cambridge, 2009
- Scholars Abstract Award, Translational Science Conference, 2013
- Award for Scholastic Achievement, American Institute for Chemical Engineers, 2008
- Member, Gold Humanism Honor Society, Stanford University School of Medicine, 2012
- Member, Alpha Omega Alpha (AOA) Medical Honor Society, 2019
- UCI Radiation Oncology Residency ASTRO/ARRO Teaching Award, 2020
- Elenora Streb Muly Undergraduate Research Scholar, Johns Hopkins University, 2004
- Joseph L. Katz Award for Excellence in Chemical Engineering, Johns Hopkins University, 2008
Areas of Expertise
- Radiation Oncology
- Thoracic Malignancies
- Soft Tissue Sarcoma Management
- Head and Neck Cancer Treatment
- Stereotactic Ablative Radiotherapy
- Financial Toxicity in Cancer
- Oligometastatic Disease
Recent Publications
- Hasan N, Yazdanpanah O, Harris JP, Nagasaka M, “Consolidative Radiotherapy in Oligometastatic and Oligoprogressive NSCLC: A Systematic Review” (opens in new tab), Critical Reviews in Oncology / Hematology, vol. 210, 2025.
- Gordon A, Rashidi A, Harris JP, Gharzai LA, Sadigh G, “Prevalence of Health-Related Social Needs and Associated Missed Imaging Appointments Among Cancer Patients” (opens in new tab), Journal of the American College of Radiology, vol. 22, pp. 861-868, 2025.
- Harada G, Ku E, Munjal A, Yeakel J, Juma S, Maxim P, Seyedin S, Nagasaka M, Chen A, Harris JP, “Observation of Acute Toxicity Events in Lung Cancer Patients Treated Concurrently with a Tyrosine Kinase Inhibitor” (opens in new tab), Cancer Treatment and Research Communications, vol. 44, 2025.
- Banks R, Munjal A, Healy E, Harris JP, “Severe Treatment-Related Toxicity in Oral Cavity Squamous Cell Carcinoma with Dyskeratosis Congenita: A Case Report and Critical Review of Radiation-Induced Complications” (opens in new tab), Advances in Radiation Oncology, vol. 10, 2025.
- Park J, Banks R, Hanubal KS, Peterson NV, Munjal A, Harada GK, Choi E, Hoyt MA, Harris JP, “Radiation Therapy Patients' Interest in Psychedelic-assisted Therapy: Results of A Survey” (opens in new tab), Radiation Oncology, vol. 20, 2025.
- Harris JP, Boyd C, Shi M, Reilly M, Simon A, Seyedin SN, Chen W-P, Nagasaka M, Nabar R, Abi-Jaoudeh N, “Pilot Study of Combining SBRT with Pulsed Field Ablation for Oligometastatic/Oligoprogressive Lung Tumors” (opens in new tab), Journal of Vascular and Interventional Radiology, vol. 36, pp. 1687-1695, 2025.
- Lee C, Harris JP, Keshava H, “Implementing a Statewide Multidisciplinary Lung Cancer Investigators Meeting and Journal Club: A University of California Lung Cancer Consortium Initiative”, 2025. Presented at Society of Thoracic Surgeons Annual Meeting, 2025, Jan 24-26.
- Tan L, Peterson N, Linskey M, Harris JP, “Case Report of a Grade 5 Toxicity Secondary to Single Fraction Cervical Spine SBRT”, 2025. Presented at ACRO 2025 Summit, 2025, March 14.
- Zhang Y, Choi I, Ku E, Shi M, Peterson N, Su M, Harris JP, “Application of MR-based Nested Habitat Radiomics for Predicting 1-Year PFS in Soft Tissue Sarcoma Patients Receiving Preoperative Radiotherapy”, 2025. Presented at International Society for Magnetic Resonance in Medicine Meeting, 2025, May 10-15.
- Peterson N, Khosravi P, Xie X, Nagasaka M, Harris JP, “Secondary Imaging Analysis of a Clinical Trial Combining SABR and PEF Ablation for Central Lung Tumors”, 2025. Presented at ASTRO 2025, 2025, Sept 28-Oct 1.
- Harada G.K., Ku E., Park J., Munjal A., Peterson N., Hsu S., Banker R., Attarian S., Healy E., Hoyt M., Sadigh G., Chen A., Harris J.P., “Financial toxicity on treatment outcomes in head & neck cancer patients undergoing radiation therapy” (opens in new tab), Radiation Oncology, vol. 20, 2025.
- Chen A.M., Harris J.P., Nabar R., Tjoa T., Haidar Y., Armstrong W.B., “Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck” (opens in new tab), Oral Oncology Reports, vol. 13, 2025.
- Chiao EJ, Harris JP, “By Your Powers Combined: Treating Pelvic Osteosarcoma with Combination Radiation and Thermoablation” (opens in new tab), International Journal of Radiation Oncology Biology Physics, vol. 118, pp. 1159-1160, 2024.
- Harris JP, Park J, Ku E, Seyedin S, Stitzlein R, Goldin A, Chen W, McLaren C, Chen AM, Chow W, “A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma” (opens in new tab), Cancer Control, vol. 31, 2024.
- Banks R, Park J, Doan L, Healy E, Harris JP, “Metastatic Pilomatrix Carcinoma Treated with Radiation: A Case Report of Radioresistance” (opens in new tab), JAAD Case Reports, vol. 47, pp. 50-53, 2024.
- Chen AM, Harris JP, Nabar R, Tjoa T, Haidar Y, Armstrong WB, “Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer” (opens in new tab), Radiotherapy and Oncology, vol. 196, 2024.
- Chen AM, Harris JP, Tjoa T, Haidar Y, Armstrong WB, “Hypofractionated Radiation Therapy Alone for Human Papillomavirus-Related Oropharyngeal Cancer” (opens in new tab), Head and Neck, vol. 47, pp. 235-241, 2024.
- Ku E, Harada G, Lee G, Munjal A, Peterson N, Park J, Chow W, Stitzlein R, Limoli C, Harris JP, “A Study of Pre- and Post-Treatment Hematologic Markers of Immune Response in Patients Undergoing Radiotherapy for Soft Tissue Sarcoma” (opens in new tab), Frontiers in Oncology, vol. 14, 2024.
- Harris JP, Abi-Jaoudeh N, Boyd C, Shi M, Reilly M, Simon A, Seyedin S, Healy E, McLaren C, Nagasaka M, Nabar R, Chen AM, “Addition of Pulsed Electric Field Ablation to SBRT for Lung Tumors: Effect on Health-Related Quality of Life”, 2024. Presented at WCLC 2024, 2024, Sep 7-10.
- Park J, Ku E, Harad G, Hoyt MA, Nagasaka M, Healy E, Harris JP, “A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research”, 2024. Presented at ASTRO 2024, 2024, Sep 29-Oct 2.
Most Cited Publications
- Harris JP, Chen MM, Orosco RK, Sirjani D, Divi V, Hara W, “Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer” (opens in new tab), JAMA Otolaryngology—Head and Neck Surgery, vol. 144, no. 4, pp. 349-359, 2018.
- Trakul N., Harris J.P., Le Q.-T., Hara W.Y., Maxim P.G., Loo B.W., Diehn M., “Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors” (opens in new tab), Journal of Thoracic Oncology, vol. 7, pp. 1462-1465, 2012.
- Chen MM, Harris JP, Orosco RK, Sirjani D, Hara W, Divi V, “The Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer” (opens in new tab), Otolaryngology Head and Neck Surgery United States, vol. 158, pp. 1051-1056, 2018.
- Harris J.P., Murphy J.D., Hanlon A.L., Le Q.-T., Loo B.W., Diehn M., “A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer” (opens in new tab), International Journal of Radiation Oncology Biology Physics, vol. 88, pp. 872-884, 2014.
- Chen M.M., Harris J.P., Hara W., Sirjani D., Divi V., “Association of postoperative radiotherapy with survival in patients with N1 oral cavity and oropharyngeal squamous cell carcinoma” (opens in new tab), JAMA Otolaryngology Head and Neck Surgery, vol. 142, pp. 1224-1230, 2016.
- Chen AM, Harris JP, Gan M, Nabar R, Tjoa T, Haidar Y, Truong A, Chow DS, Armstrong WB, “Posttreatment Surveillance Imaging After Radiation for Head and Neck Cancer” (opens in new tab), JAMA Network Open, vol. 6, pp. E2342825, 2023.
- Chen JJ, Harris JP, Kong C, Sunwoo JB, Divi V, Horst KC, Aasi SZ, Hollmig ST, Hara W, “Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis” (opens in new tab), Oral Oncology, vol. 85, pp. 60-67, 2018.
- Harris JP, Patel MI, Loo BW, Wakelee HA, Diehn M, “A Population-Based Comparative Effectiveness Study of Chemoradiation Regimens in Stage III Non-Small Cell Lung Cancer” (opens in new tab), Lung Cancer, vol. 108, pp. 173-182, 2017.
- Harris JP, Saraswathula A, Kaplun B, Qian Y, Chan KCA, Chan ATC, Le QT, Owens DK, Goldhaber-Fiebert JD, Pollom E, “Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma for Asian-American Men in the US” (opens in new tab), Otolaryngology Head and Neck Surgery United States, vol. 161, no. 1, pp. 82-90, 2019.
- Harris JP, Kashyap M, Humphreys JN, Chang DT, Pollom EL, “Longitudinal Analysis of Mental Disorders Among Elderly Patients with Gastrointestinal Malignancies” (opens in new tab), Jnccn Journal of the National Comprehensive Cancer Network, vol. 19, pp. 163-171, 2021.
Contact Information
Website: https://www.faculty.uci.edu/profile/?facultyId=7055
Email: jpharris1@uci.edu
Phone: 714-456-8095
Return to topThis profile was created with the help of AI.
Last updated on 3/14/2026.